Chiesi
chiesi.ru
Actively hiring
Pharmaceuticals
Manufacturing
Science & Engineering
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
RU EN Контакты Домой О компании История Миссия и ценности Ежегодный отчет об устойчивом развитии B Corp и Корпорация общественного блага СОУТ Исследования Люди в центре Терапевтические области Air Rare Care Опытные профессионалы Раскрытие информации о передаче ценностей---- Раскрытие информации о…
News
Chiesi Global Rare Diseases Demonstrates Its Ongoing Commitment to the Rare Disease Community at the Society of Inborn Errors of Metabolism (SSIEM) 2026 Annual Symposium
-- Chiesi's abstract presentations highlight clinical insights and patient-reported outcomes inFabry disease and alpha-mannosidosis ---- Rooted in...
Read more
Report
Chiesi survey shows how Fabry drugs are failing patients, providing road map for ousting incumbents
Read more
Report
Chiesi Group
--In 2023, Chiesi, a research-oriented international biopharmaceutical group headquartered in Parma, with 31 affiliates worldwide, showcased the efficacy of its operating model centred around shared value, sustainability, and high ethical standards. Throu
Read more
Report
Pro access
Upgrade to see all 6 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.